OUR PRESS RELEASES AND NEWS UPDATES

These press releases and news updates are intended for media and investors only

Showing results for

These press releases and news updates are intended for media and investors only

Media contacts

Media contact details for our global headquarters and USA. For press contacts in our local operating companies please visit our country websites.

In you have a media query please use our Contact our team form here.

Global Press Office

Rachel Jaikaran
Head of Global Communications ViiV Healthcare
Tel: +44 7909 00240

 

US Press Office

Audrey Abernathy
Head of ViiV US External Affairs & Communications
Tel: +1 919 605 4521

NP-GBL-HVX-COCO-220024 November 2021.

Reporting of side effects

If you get any side effects, talk to your doctor, pharmacist, or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the GSK Reporting Tool link https://gsk.public.reportum.com/. By reporting side effects, you can help provide more information on the safety of this medicine.

If you are from outside the UK, you can report adverse events to GSK/ ViiV by selecting your region and market, here.